Snyder is still with the Diamondbacks … for now

0 Comments

Back in November the Blue Jays called off a Lyle Overbay-for-Chris Snyder swap and then in December the Diamondbacks offered Snyder to the Rangers for C.J. Wilson, only to have Texas predictably turn it down and Wilson tweet about how he was “borderline offended” by the offer.
Since then Snyder’s name hasn’t popped up in trade rumors much despite Arizona being committed to Miguel Montero as the starter and several teams needing upgrades behind the plate. “Obviously we had those discussions and made an attempt early and there is a point at which it becomes less realistic,” general manager Josh Byrnes told MLB.com’s Steve Gilbert. “So right now I think it’s prudent to assume that’s going to be our catching combination.”
Montero bats left-handed and Snyder bats right-handed, so they make for a nice platoon, but my guess is that Byrnes and the Diamondbacks remain very willing to part with Snyder for any kind of decent value. One issue is that Snyder is coming off back surgery and another issue is that he’s owed $11 million over the next two years, so first he’ll need to prove that he’s healthy and then the Diamondbacks may need to eat some salary.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.